ViewpointThe Health Impact Fund: incentives for improving access to medicines
References (21)
WHO: the casualties and compromises of renewal
Lancet
(2002)Okinawa Summit
- et al.
The developing world is poorer than we thought, but no less successful in the fight against poverty. World Bank Policy Research Working Paper WPS 4703, 2008: 34
United Nations Millennium Development Goals
The World Summit on Sustainable Development: reaffirming the centrality of health
Global Health
(2005)Big pharma as a catalyst for change. February 13, 2009 Speech to Harvard Medical School
Pharmaceuticals, patents, publicity…and philanthropy?
Lancet
(2009)An uncertain future for cardiovascular drug development?
N Engl J Med
(2009)The world drug situation
(1988)Chronic Diseases Report 2005. Chapter 2: chronic diseases and poverty
(2005)
There are more references available in the full text version of this article.
Cited by (68)
The economic challenges of new drug development
2022, Journal of Controlled ReleaseCitation Excerpt :If achieving this seems challenging in the context of antibiotics, where all countries are likely to see clear benefits, how could such a model possibly work in the context of diseases that mainly affect people in poor countries? One possibility lies in a system such as the Health Impact Fund (HIF) [17]. The basic idea of the HIF is to create a global government-funded agency that offers yearly reward pools from which new drugs can receive a share for a fixed period of time (e.g. 10 years), corresponding to the drug's contribution to the global health impact of all HIF-registered drugs.
Patient Benefit of Clinical Research in Diversely Advanced African Developing Countries
2022, Current Therapeutic Research - Clinical and ExperimentalMarket outcomes and dynamic patent buyouts
2016, International Journal of Industrial OrganizationPharmaceutical patenting and the transformation of American medical ethics
2016, British Journal for the History of SciencePull me – push you? The disparate financing mechanisms of drug research in global health
2024, Globalization and Health
Copyright © 2010 Elsevier Ltd. All rights reserved.